ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Yilei Mao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0449-4223; OpenAlex author ID A5088394227. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 3

Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. Last author DOI 10.1016/j.jare.2024.09.011 ↗
Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.suronc.2022.101849 ↗
Quantitative definitions of prognostic indicators of resectable pancreatic cancer. Last author DOI 10.21037/gs-22-354 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huayu Yang · 2 shared papers, 2022–2025 · strength 0.46
- Paper Quantitative definitions of prognostic indicators of resectable pancreatic cancer. DOI 10.21037/gs-22-354 ↗
- Paper Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. DOI 10.1016/j.jare.2024.09.011 ↗
Hang Sun · 2 shared papers, 2022–2025 · strength 0.46
- Paper Quantitative definitions of prognostic indicators of resectable pancreatic cancer. DOI 10.21037/gs-22-354 ↗
- Paper Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. DOI 10.1016/j.jare.2024.09.011 ↗
Yao Xiao · 1 shared paper, 2022 · strength 0.17
- Paper Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2022.101849 ↗
Jordan M. Cloyd · 1 shared paper, 2022 · strength 0.17
- Paper Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2022.101849 ↗
Timothy Michael Pawlik · 1 shared paper, 2022 · strength 0.17
- Paper Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2022.101849 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.